Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA06	MYFORTIC	B	Mycophenolic acid (sodium) - 360mg	360mg	Tablet, gastroresistant	L.L
J01DH02	MERONEM	B	Meropenem (trihydrate) - 500mg	500mg	Injectable powder for solution	10,398,061 L.L
H05BA01	MIACALCIC	B	Calcitonin (salmon synthetic) - 100IU/ml	100IU/ml	Injectable solution	1,720,118 L.L
C08DB01	MONO-TILDIEM LP/SR	B	Diltiazem HCl - 200mg	200mg	Capsule, sustained release	658,483 L.L
H05BA01	MIACALCIC 200 UI/ACTUATION	B	Calcitonin (salmon synthetic) - 200IU/actuation	200IU/actuation	Solution	5,399,559 L.L
C08DB01	MONO-TILDIEM LP/SR	B	Diltiazem HCl - 300mg	300mg	Capsule, sustained release	658,483 L.L
J01DH02	MERONEM	B	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	10,398,061 L.L
N07AA02	MESTINON	B	Pyridostigmine bromide - 60mg	60mg	Tablet, sugar coated	3,090,838 L.L
R05CB06	MUCOSOLVAN	B	Ambroxol HCl - 30mg/5ml	30mg/5ml	Syrup	380,307 L.L
N02CC04	MAXALT	B	Rizatriptan (benzoate) - 10mg		Tablet	439,436 L.L
R05CB06	MUCOSOLVAN LA	B	Ambroxol HCl - 75mg	75mg	Capsule	345,368 L.L
G03GA02	MENO-CLAIR HP-HMG	BioHuman	Human Menopausal Gonadotrophin, Highly purified - 75IU	75IU	Injectable powder for solution + solution	1,045,509 L.L
G03GA02	MENOPUR	BioHuman	Menotropin - 75IU	75IU	Injectable concentrated powder for solution+diluent	16,864,077 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 75IU	75IU	Injectable powder + solvent	24,771,315 L.L
G03GA02	MENOPUR	BioHuman	Menotropin - 1,200IU	1,200IU	Injectable powder for solution+diluent	27,815,659 L.L
G03GA02	MENOPUR	BioHuman	Menotropin - 600IU	600IU	Injectable powder for solution+diluent	13,907,829 L.L
G03GA02	MENO-CLAIR HP-HMG	BioHuman	Human Menopausal Gonadotrophin, Highly purified - 150IU	150IU	Injectable powder for solution + solution	2,005,013 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 150IU	150IU	Injectable powder + solvent	41,777,992 L.L
G03GA02	MERIONAL HG	BioHuman	Menotropin - 900IU	900IU	Injectable powder + solvent	25,830,983 L.L
L01EE03	MEKTOVI	BioTech	Binimetinib - 15mg	15mg	Tablet, film coated	257,694,409 L.L
A10AD01	MIXTARD 30	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AD01	MIXTARD 30	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	22,183,393 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	11,091,696 L.L
L01FA01	MABTHERA	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrated solution	35,722,424 L.L
L01FA01	MABIXEN 500	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	136,761,210 L.L
L01FA01	MABIXEN 500	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrate for solution	74,718,320 L.L
A16AB07	MYOZYME	BioTech	Alglucosidase alfa, recombinant human acid - 50mg	50mg	Injectable powder for concentrate for solution	L.L
L01FA01	MABTHERA	BioTech	Rituximab - 500mg/50ml	500mg/50ml	Injectable concentrated solution	80,211,932 L.L
L01FD01	MABTIN 440	BioTech	Trastuzumab (r-DNA origin) - 440mg	440mg	Injectable powder for solution	70,042,700 L.L

...